3rd Party Biotechnology Industry News

In a reminder of the money still available for enticing [...]

Corcept Therapeutics’ relacorilant has improved overall survival in a phase [...]

Bristol Myers Squibb will pay T-cell engager company Janux Therapeutics [...]

After a short delay and concerns of potential intervention from [...]

Novo Nordisk has found a buyer for cell therapy technologies [...]

Cancer imaging company Kuva Labs is expanding its scope via [...]

Only four months after IO Biotech decided to halve its [...]

Tanabe Pharma America’s small molecule designed to boost melanin production [...]

Pfizer is paying $30 million to use Novavax’s adjuvant technology [...]

Boundless Bio has finally given up on its hopes of [...]